MD or equivalent medical degree required. Advanced knowledge and clinical training in a medical/scientific area (e.g., internal medicine / pharmacology etc.) with medical council certification required.
Faculty who can successfully execute R&D and consultancy will be preferred. Faculty who can promote patents, Entrepreneurship Development Cell, Innovative, Industry Interaction, and other value-added courses will be preferred.
M.Sc in Life Science / M.Pharm from recognized University or Equivalent with NET/GATE qualified. National Institute for Interdisciplinary Science and Technology
B.Pharmacy from any recognized institute Or approved diploma in Pharmacy from an institute recognized by the Pharmacy council of India and registered as pharmacist under Pharmacy Act 1948
Post Graduate in Life Sciences, Microbiology, Biotechnology, Biochemistry. NET / GATE qualification or any national eligibility test is mandatory. Institute of Liver and Biliary Sciences ILBS is a tertiary care, super-specialty hospital
B.Sc., M.Sc., B.Pharm, M.Pharm; Cliantha QC Lab Reviewer and QA Lab Auditor. Research QC ensures compliance with regulatory standards by maintaining the quality of data for both small and large molecule bioanalytical laboratories.
Literature review for product development for US/ EU/ ROW market especially complex injectable’s like Liposomes, Nanoparticle suspension, Microspheres, Suspension’s, Emulsion’s, Lyophilized products, Peptide Injectable’s, Drug delivery systems.
LENZ Therapeutics, Inc announced the US Food and Drug Administration approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults. Samples are anticipated in the United States as early as October 2025, with commercial product to be broadly available by mid-Q4 2025. Direct-to-eye care professional sales and marketing activities to be initiated immediately.
AbbVie announced positive topline results from the first of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ®; 15 mg and 30 mg, once daily) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline SALT score of 83.8 (approximately 16% scalp hair coverage).
M.Pharm / M.Sc in Pharmaceutical Sciences / Pharmaceutics / Chemistry with specialization in Organic / Medicinal Chemistry / Life Science / Biotechnology with GATE/GPAT.
Masters in Pharmacy / Doctor of Pharmacy - Good knowledge of computers is desirable. 0–1 year experience in Pharmacovigilance / Surveillance / Medical Devices / Quality Assurance / Regulatory Affairs or Quality Management System